Express Scripts Gets Clients Involved In Price War With Drug Maker

Photo courtesy of Creative Commons
Courtesy of Creative Commons

Express Scripts Inc. is escalating its price war with Gilead Sciences Inc. in an effort to force the drug maker to cut the $84,000 price of its new hepatitis C pill. Express Scripts is planning to ask its clients — which include large national employers, insurance plans and government agencies — to join a coalition that would cease to use Gilead’s Solvadi medication once a rival medication is approved for use in the U.S., Bloomberg reports.

A rival medication is expected to receive U.S. approval next year. In December, Express Scripts said it might block the Solvadi pill from reimbursement if competing drug companies accept lower pricing. Solvadi costs $1,000 per pill, and a regular course of treatment includes one pill daily for 12 weeks.

Read more from the St. Louis Business Journal

Tags:, ,

Leave a Reply

Have you heard?

Missouri Business Alert is participating in CoMoGives2019!

Find out how we plan to use your gift to enhance training and programming for our students